This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date : 02/26/2018 - 02/26/2018
Location : Silver Spring, MD
Subject : FDA's New Comprehensive Plan for Tobacco and Nicotine Regulation
FDA Participant/Group : KELLEY NDUOM; KATHLEEN QUINN; JOSEPHINE TROPEA; CARLYLE MCWILLIAMS; ANNA ABRAM; DAVID MARKERT; LAUREN SILVIS; AMANDA SUTARIA; MITCHELL ZELLER; RICHARD TURMAN; MICHELE MITAL;
Non FDA Participant/Group : Joseph P. Fragnito (R.J. Reynolds Tobacco Company); James Figlar, Michael Ogden, Mitch Neuhauser, Rich Haselwood (Reynolds American Incorporated);

Event Date : 02/27/2018 - 02/27/2018
Location : Silver Spring, MD
Subject : FDA's New Comprehensive Plan for Tobacco and Nicotine Regulation
FDA Participant/Group : MICHELE MITAL; ANNA ABRAM; RICHARD TURMAN; CARLYLE MCWILLIAMS; JOSEPHINE TROPEA; MITCHELL ZELLER; KATHLEEN QUINN; LAUREN SILVIS; JENNIFER CARUSO;
Non FDA Participant/Group : Carlos Fuente, Jorge Padron, Robert Levin, Rocky Patel (Cigar Rights of America); Craig Cass, Daniel Trope, Greg Zimmerman (International Premium Cigar & Pipe Retailers Association); Will Woodlee (Kleinfeld, Kaplan & Becker); Dennis Potter (K & L Gates LLP);

Event Date : 02/28/2018 - 02/28/2018
Location : Silver Spring, MD
Subject : Public Meeting: Enhanced Drug Distribution Security Under the Drug Supply Chain Security Act
FDA Participant/Group : Several FDA staff participants
Non FDA Participant/Group : Supply chain stakeholders (manufacturers, wholesalers, dispensers, solution providers, consultants, government employees and other registered individuals);

Event Date : 03/01/2018 - 03/01/2018
Location : Washington, DC
Subject : Combating the Opioid Crisis: From Communities to the Capital
FDA Participant/Group : JENNIFER RODRIGUEZ;
Non FDA Participant/Group : Federal, state, and local government agencies, media, academia, industry, and medical professionals

Official Name : Rachel Sherman, M.D., M.P.H.,, Principal Deputy Commissioner

No Significant Event

Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name : Mark Abdoo , Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name : Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

Event Date : 02/27/2018
Location : Covington, KY
Subject : The Produce Safety Alliance Water Summit: Food Safety Modernization Act (FSMA) Produce Safety Rule
FDA Participant/Group : N/A
Non FDA Participant/Group : Several members (Produce Safety Alliance);

Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name : Jennifer Rodriguez, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name : RADM Denise Hinton , Acting Chief Scientist

No Significant Event

Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date : 02/26/2018 - 02/27/2018
Location : Austin, Texas
Subject : International Conference on Drug Development: CDER Perspective: 21st Century Cures Act and PDUFA VI
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date : 03/01/2018 - 03/01/2018
Location : Bethesda, MD
Subject : Rare Disease Day Meeting
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date : 02/26/2018 - 02/26/2018
Location : Washington, DC
Subject : National Evaluation System for Health Technology Coordinating Center: Governing Committee Meeting
FDA Participant/Group : DOUGLAS DUMONT; JOSHUA CHETTA; DANIEL CANOS; GREGORY PAPPAS;
Non FDA Participant/Group : Rachael Fleurence, Rachel Rath, Tiffany Abushaikha and Nirav Dalal (Medical Device Innovation Consortium);

Event Date : 03/01/2018 - 03/01/2018
Location : Washington, DC
Subject : Advance Medical Technology Association Senior Regulatory Group Meeting: CDRH 2018 Priorities
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name : Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name : Rebecca K. Wood, J.D., Chief Counsel

No Significant Event